Quality of life in patients with thyroid eye disease

Journal of Ophthalmic and Vision Research

Volumn 4, Issue 3, 2009, Pages 164-168

  Bahmani Kashkouli, Mohsen ^a   Pakdel, Farzad ^a   Astaraki, Arezoo ^a   Hashemi, Masih ^a   Honarbakhsh, Yasamin ^a   Mirarmandehi, Bahareh ^a   Jam, Sara ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Graves ophthalmopathy; Quality of life

Indexed keywords

EID: 84897585316     PISSN: 20082010     EISSN: 2008322X     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Terwee CB, Gerding MN, Dekker FW, Prummel MF, Wiersinga WM. Development of a disease specific quality of life questionnaire for patients with Grave's ophthalmopathy: The GO-QOL. Br J Ophthalmol 1998;82:773-779.
2. Park JJ, Sullivan TJ, Mortimer RH, Wagenaar M, Perry-Keene DA. Assessing quality of life in Australian patients with thyroid eye disease. Br J Ophthalmol 2004;88:75-78.
3. Wiersinga WM, Bartalena L. Epidemiology and prevention of Graves' ophthalmopathy. Thyroid 2002;12:855-860.
4. Rootman J, Dolman PJ. Thyroid orbitopathy. In: Rootman J (ed). Diseases of the orbit, a multidisciplinary approach. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2003: 169-212.
5. Farid M, Roch-Levecq AC, Levi L, Brody BL, Granet DB, Kikkawa DO. Psychosocial disturbance in graves ophthalmopathy. Arch Ophthalmol 2005;123:491-496.
6. Perez Moreiras JV, Coloma Bockos JE, Prada Sanchez MC. Thyroid orbitopathy (pathogenesis, diagnosis, and treatment). Arch Soc Esp Oftalmol 2003;78:407-431.
7. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 1995; 273:59-65.
8. Kahaly GJ, Hardt J, Petrak F, Egle UT. Psychosocial factors in subjects with thyroid-associated ophthalmopathy. Thyroid 2002;12:237-239.
9. Elberling TV, Rasmussen AK, Feldt-Rasmussen U, Hørding M, Perrild H, Waldemar G. Impaired health-related quality of life in Graves' disease. A prospective study. Eur J Endocrinol 2004;151:549-555.
10. Testa MA, Simonson DC. Assessment of quality-oflife outcomes. N Engl J Med 1996;334:835-840.
11. Prummel MF, Wiersinga WM. Smoking and risk of Graves' disease. JAMA 1993; 269:479-482.
12. Gerding MN, Terwee CB, Dekker FW, Koornneef L, Prummel MF, Wiersinga WM. Quality of life in patients with Graves' ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid 1997;7:885-889.
13. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD, et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA 1989;262:907-913.
14. de Boer AG, Wijker W, Bartelsman JF, de Haes HC. Inflammatory Bowel Disease Questionnaire: crosscultural adaptation and further validation. Eur J Gastroenterol Hepatol 1995;7:1043-1050.
15. Terwee CB, Gerding MN, Dekker FW, Prummel MF, van der Pol JP, Wiersinga WM. Test-Retest Reliability of the GO-QOL; a disease-specific quality of life questionnaire for patients with Grave's ophthalmopathy. J Clin Epidemiol 1999;52:875-884.
16. Werner SC. Modification of the classification of the eye changes of Graves' disease. Am J Ophthalmol 1977;83:725-727.
17. Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol 1989;73:639-644.
18. Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, et al. Long term follow up of Graves ophthalmopathy in an incidence cohort. Ophthalmology 1996;103:958-962.
19. Terwee CB, Dekker FW, Mourits MP, Gerding MN, Baldeschi L, Kalmann R, et al. Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GOQOL) after different treatments. Clin Endocrinol (Oxf) 2001;54:391-395.
20. Wiersinga WM, Prumnel MF, Terwee CB. Effects of Graves' ophthalmopathy on quality of life. J Endocrinol Invest 2004;27:259-264.
21. Alosono J, Anto JM, Gonzalez M, Fiz JA, Izquierdo J, Morera J. Measurement of general health status of non-oxygen-dependent chronic obstructive pulmonary disease patients. Med Care 1992;30:125-135.
22. Peterson WL, Sturdevant RA, Frankl HD, Richardson CT, Isenberg JI, Elashoff JD, et al. Healing of duodenal ulcer with an antacid regimen. N Eng J Med1977;297:341-345.